The latest health news
While pharma companies struggle to show that cutting-edge therapies can treat, prevent, or slow Alzheimer’s disease and other forms of dementia, a new study suggests that a far simpler and …
Read More
Will biotech stocks ever recover? How well do Covid-19 vaccines work for kids? And can anything stop the amyloid hypothesis? We cover all that and more this week on “The …
Read More
When Alzheimer’s disease was believed to be caused solely by the accumulation of amyloid protein in the brain, pinning all hopes on an amyloid-targeting drug like Aduhelm — the first …
Read More
BERLIN — Looking more like a barber than a doctor, orthopedic surgeon Musa Citak squirted gel on his patient’s head and massaged the gooey substance into his scalp as though …
Read More
For a human, one of the first signs someone is getting old is the inability to remember little things; maybe they misplace their keys, or get lost on an oft-taken …
Read More
Who’s going to run Biogen? Does Aduhelm have a future? And is it OK to shame reporters? We cover all that and more this week on “The Readout LOUD,” STAT’s …
Read More
Biogen’s announcement on Tuesday that it is “substantially eliminating” its spending on Aduhelm caps a remarkable story of drug development gone bad. In a controversial move in June 2021, the …
Read More
The Centers for Medicare and Medicaid Services (CMS) issued on Thursday its hotly debated final decision on whether to cover aducanumab (Aduhelm), the first FDA-approved treatment for Alzheimer’s that slows …
Read More
In a clash of two American health care giants, the Centers for Medicare and Medicaid Services (CMS) and the Food and Drug Administration (FDA) had locked horns over Aduhelm, a …
Read More